Suomen sivusto, jossa voit ostaa halvalla ja laadukas Viagra http://osta-apteekki.com/ toimitus kaikkialle maailmaan.

Yritti äskettäin viagra, se toimii erittäin tehokkaasti)) Ostaa Internetin kautta täällä propecia Myös ostaa levitra oikeudenkäynti, vaikutus on silmiinpistävää.

Physicians.denverhealth.org

Curriculum Vitae
Irina M. Pines, MD

Address:

Denver Health 700 Delaware St. Denver, CO 80206
Education:
1978
B.S. Kaunas Medical Institute, Lithuania M.D. Kaunas Medical Institute, Lithuania
Postdoctoral Training:
1981-1982
Intern in Medicine and Cardiology, Vilnius, Lithuania internal Medicine Residency, Presbyterian/St. Luke’s Medical Center, Denver, CO
Examinations Passed:
1991

Licensure and Certification:
1996
American Board of Internal Medicine #170976 Instructor in Medicine, Division of General Internal Medicine, University of Colorado Health Sciences Center Assistant Professor of Medicine, Division of General Internal Medicine, University of Colorado Health Sciences Center
Hospital Appointments:
1997-present Denver Health Medical Center, Denver, CO
Practice Appointments:
1982-1989
Bobruisk Clinical Hospital, Belarus, Physician Internal Medicine Clinic Experience with Dr. Lee Anneberg, Denver, CO
Curriculum Vitae
Irina M. Pines, MD

The Colorado Prevention Center, Co Investigator & Principal Investigator for multiple cardiovascular prevention research studies, Cardiovascular Disease Prevention Program in Russian Immigrants Medical Safety Officer, Sigma-Tau Trial, “Safety and Efficacy of Propionyl-L-Carnitine in Peripheral Arterial Disease (Intermittent Claudication) as Assessed by a Graded Treadmill Protocol In a Well Defined Target Population, A Multi-Center Study” Principal Investigator, CHARISMA, “Clopidogrel for High Atherothrombotic Risk and Ischemic, Stabilization, Management, and Avoidance” Principal Investigator, Vasogen SIMPADICO trial, “A Multicenter, Double Blind Parallel Group, Placebo-Controlled Study of Efficacy and Safety of Immune Modulation Therapy on Improving Walking Distance in Patients with Intermittent Claudication Secondary to Peripheral Arterial Disease” Sub-Investigator, EXPLORE, “A Multicenter, Double Blind, Randomized Study with Two Parallel Groups Comparing the Effects of 12 weeks of Treatment with Lotrel™ (amlodipine/benazapril) to those of Amiodipine on Endothelial Function in Hypertensive Subjects“ Sub-Investigator, ABBOTT, “A Phase 4b, Randomized, open-Label, Active-Controlled Study to Compare the effects of Tarka® and Lotrel ® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects with Diabetic Nephropathy” Lead Medical Liaison for endpoint evaluation and training visits to Russian investigative sites for protocol, ICPOP, “The Effect of Niacin ER/Lovastatin on Peak Walking Time in Patients with Intermittent Claudication” Lead Medical Liaison for endpoint evaluation and training visits to Russian Investigative site for protocol, ActivBiotics Presented ActivBiotics Investigation’s Meeting in St. Petersburg, Russia Co-Investigator of CRESCENDO study at the Colorado Prevention Center
Committee Memberships:
2000-2006
IRB – Member of Colorado Institutional Board Committee
Community Activities and Prevention:
Conduct lectures and discussions in the Russian Community regarding prevention and treatment of cardiovascular diseases, diabetes, HTN, PVD, etc., Publications and Abstracts:
A Community Study of Language Concordance in Russian Patients with Diabetes. “Cultural Issues in Primary Care of Russian Immigrants, “Society of General Internal Medicine, Chicago, Illinois – May 14, 2004.

Source: http://physicians.denverhealth.org/Custom/PhysicianFileUploads/CVUploads/Irina-Pines-CV.pdf

janaushadhi.gov.in

Price List of Jan Aushadhi Medicines September 2013 Generic Name of the Medicines Strip/Unit MRP per unit ANALGESIC/ ANTI-INFLAMMATORY/ MUSCLOSKELETAL DISORDER Aceclofenac + Paracetamol (100 mg + 500mg) TabAcetaminophen + Tramadol Hydrochloride (325 mg + 37.5Chlorzoxazone + Diclofenac + Paracetamol (500 mg + 50Diclofenac Sodium + Serratiopeptidase (50mg + 10mg)Ibuprofen +

cme-medipoint.de

in der Therapie des Diabetes mellitus Typ 2Lernkontrollfragen Modul 2 »DPP-IV-Inhibtoren in der Therapie von geriatrischen und niereninsuffizienten Diabetes-Patienten« Bitte kreuzen Sie jeweils nur eine Antwort an. 1. Wieviel Prozent der Diabetespatienten sind älter als 65 Jahre? 2. Welche Aussage zu geriatrischen Patienten ist falsch? a) Geriatrische Patienten leiden häufig an Dep

Copyright © 2010-2014 Medical Pdf Articles